Representation in Clinical Trials

April 16, 2024
MarketScale

Research institutions have long struggled with accurate population representation in clinical trials. The growing proliferation of digital in healthcare ecosystems makes this more likely, but it is not perfect. UCLA Health’s Dr. Arash Naeim and Dr. Medell Briggs-Malonson share their efforts to progress the intersectionality of health technology and health audience in clinical trials and beyond. Verizon’s Robin Goldsmith and Ned Chini round out this conversation with the role devices and connectivity play in achieving representation.

Recent Episodes

sustainability in healthcare
View episode

As the health sector grapples with evolving challenges, sustainability in healthcare emerges as a critical focal point. The healthcare industry faces increasing pressure to adapt amid global conflicts, inflation, and rising environmental concerns. According to The Commonwealth Fund, healthcare contributes 8.5% of the U.S. carbon footprint. With this backdrop, healthcare organizations must explore ways…

Get Ready for 'Care Anywhere': The Upcoming Podcast Changing the Narrative of Global Healthcare
View episode

The excitement that surrounds the launch of ‘Care Anywhere,’ a podcast by CGFNS International, Inc. can hardly be condensed into words. This new show, hosted by CMO, Lea Sims of CGFNS International, Inc., seeks to drive significant conversations around the global perimeters of healthcare. The podcast takes a keen interest in healthcare workers’ growth, training,…

boom of digital health
View episode

The boom of digital health has been a widely discussed topic in recent years, with many claiming it is a game-changing revolution in the healthcare sector. As the healthcare landscape continues to evolve with rapid technological advancements, questions arise about whether the boom of digital health is truly meeting its expectations. This pressing question…